Results 1 to 10 of about 7,356,650 (144)

Success Rates of Assisted Reproduction in Couples with Poor Ovarian Response and Oligospermia [PDF]

Cells
Recent progress in assisted reproductive medicine has introduced novel therapeutic possibilities for couples experiencing various reproductive challenges or subfertility.
Jakub Wyroba, Joanna Kochan, Maciej Brązert, Paweł Kordowitzki   +3 more
doaj   +3 more sources

Management of Poor Ovarian Response

Fertility & Reproduction, 2023
Poor ovarian response (POR) occurs in approximately 9-24% of patients in ART. It presents a challenge to the reproductive consultant and causes immense emotional distress to the couple.
Nalini Kaul - Mahajan
doaj   +2 more sources

Poor ovarian response and the possible role of natural and modified natural cycles

Therapeutic Advances in Reproductive Health, 2022
About 20% of women undergoing in vitro fertilization struggle with poor ovarian response, indicating a poor prognosis related to low response following ovarian stimulation.
Federica Di Guardo, Christophe Blockeel, Michel De Vos, Marco Palumbo, Nikolaos Christoforidis, Herman Tournaye, Panagiotis Drakopoulos   +6 more
doaj   +2 more sources

Autologous platelet-rich plasma ovarian injection was associated with increased oocyte acquisition in patients with poor ovarian response: a retrospective propensity-matched study [PDF]

BMC Pregnancy and Childbirth
Background Women with poor ovarian response (POR) tended to have lower success rates for IVF/ICSI due to fewer oocytes retrieved. Autologous platelet-rich plasma (PRP) has been proposed to improve ovarian response. Method This study aimed to evaluate the
Qian Li, Jing Li , Jia-wen Liu , Ya-jie Chang , Ying-ying Liu , Li-na Zou , Cong Fang , Xiao-yan Liang   +7 more
doaj   +2 more sources

Efficacy of intraovarian injection of autologous platelet-rich plasma on outcome of in vitro fertilization in women with poor ovarian response: A systematic review [PDF]

International Journal of Reproductive BioMedicine
Background: The beneficial and long-term effects of ovarian platelet-rich plasma (PRP) in assisted reproductive technology cycles are still debatable. Objective: The aim of the current study is to determine the effect of ovarian PRP on the outcome of
Marzieh Zamaniyan, Sepideh Peivandi, Maryam Pashazadeh, Farnaz Safarloo   +3 more
doaj   +2 more sources

Development and validation of a prediction model for unexpected poor ovarian response during IVF/ICSI [PDF]

Frontiers in Endocrinology
BackgroundIdentifying poor ovarian response (POR) among patients with good ovarian reserve poses a significant challenge within reproductive medicine.
Xiaohang Xu, Xiaohang Xu, Xue Wang, Xue Wang, Yilin Jiang, Yilin Jiang, Haoyue Sun, Haoyue Sun, Yuanhui Chen, Yuanhui Chen, Cuilian Zhang   +10 more
doaj   +2 more sources

The Role of Androgen Supplementation in Women With Diminished Ovarian Reserve: Time to Randomize, Not Meta-Analyze

Frontiers in Endocrinology, 2021
The management of patients with diminished ovarian reserve (DOR) remains one of the most challenging tasks in IVF clinical practice. Despite the promising results obtained from animal studies regarding the importance of androgens on folliculogenesis, the
Ana Raquel Neves, Ana Raquel Neves, Pedro Montoya-Botero, Nikolaos P. Polyzos, Nikolaos P. Polyzos   +4 more
doaj   +1 more source

In Vitro Follicular Activation and Stem Cell Therapy as a Novel Treatment Strategies in Diminished Ovarian Reserve and Primary Ovarian Insufficiency

Frontiers in Endocrinology, 2021
Usually poor ovarian response (POR) to gonadotropins reflects a diminished ovarian reserve (DOR) that gives place to few recruitable follicles despite aggressive stimulation.
Francesc Fàbregues, Francesc Fàbregues, Janisse Ferreri, Marta Méndez, Josep María Calafell, Jordi Otero, Ramon Farré, Ramon Farré, Ramon Farré   +8 more
doaj   +1 more source

Corifollitropin alfa in different variants of ovarian response in assisted reproductive technology programmes: literature review

Медицинский совет, 2021
This literature review focuses on the use of corifollitropin alfa for ovarian stimulation in assisted reproductive technology (ART) programmes in different groups of patients. Corifollitropin alfa is a gonadotropin drug with prolonged FSH activity.
A. G. Syrkasheva, D. M. Ermakova
doaj   +1 more source

Clinical and laboratory criteria for occult form of premature ovarian failure [PDF]

Гинекология, 2018
Purpose of the study. To develop clinical and laboratory criteria characteristic of the occult (hidden) form of premature ovarian failure. Material and methods.
L A Marchenko, R I Mashaeva
doaj   +1 more source